Chemours stock gets a USD 18.00 BMO target after Q2 loss

Published on 10/08/2026 at 03:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Chemours stock posted USD 1.591 billion in Q2 revenue on June 30, 2026, versus USD 1.615 billion a year earlier. GAAP loss narrowed to USD 274 million from USD 381 million.

CC, US1638511089, Illustration mit AI erstellt.

Chemours stock (ISIN US1638511089) was quoted at USD 14.06 on the NYSE on October 7, 2026, placing it 51.0 percent below its 52-week high of USD 28.67. The fresh analyst signal came from BMO Capital, which maintained a Buy rating and set an USD 18.00 price target on October 5, 2026, according to Markets Insider.

Q2 revenue fell 1.5 percent

In its September 9, 2026 filing, Chemours reported second-quarter 2026 revenue of USD 1.591 billion, down from USD 1.615 billion in the second quarter of 2025. The comparison represents a 1.5 percent year-over-year decline.

The same filing showed a GAAP net loss of USD 274 million for the quarter ended June 30, 2026, compared with a GAAP net loss of USD 380 million a year earlier. The smaller loss improves the year-over-year comparison, but the company remained loss-making on a GAAP basis.

Analysts see upside to USD 18.78

The analyst consensus for Chemours was Outperform among 9 analysts, with an average target of USD 18.78, according to MarketScreener. That consensus target is USD 4.72 above the October 7 quotation, while BMO's USD 18.00 target is USD 3.94 higher.

UBS took a more cautious view on October 5, lowering its target to USD 16.00 from USD 18.00 while keeping a Neutral rating, as reported by Markets Insider. The split between BMO's Buy rating and UBS's Neutral stance leaves the earnings trend and balance-sheet progress central to the investment case.

Stock remains below its yearly high

Chemours had a 52-week range of USD 10.44 to USD 28.67 on October 7, 2026. Its quoted price of USD 14.06 therefore stood USD 3.62 above the yearly low and USD 14.61 below the yearly high.

Market capitalization was USD 2.1 billion on October 7, 2026, while the latest quarterly operating figures showed USD 1.591 billion in revenue and a USD 274 million GAAP loss. The valuation picture therefore combines a modest equity value with a business still working through profitability pressure.